What Remicade treats
Remicade (infliximab) is a biologic medication used to treat a variety of autoimmune conditions, including moderate to severe rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and psoriatic arthritis. It works by targeting and inhibiting tumor necrosis factor-alpha (TNF-alpha), a protein involved in the inflammatory process. Remicade helps reduce inflammation, improve symptoms, and manage these chronic conditions.
Benefits of Remicade
Patients using Remicade often experience significant benefits, including reduced inflammation, fewer disease flares, and improved symptoms such as joint pain and gastrointestinal distress. For those with autoimmune conditions, Remicade can lead to better disease control and improved overall functioning. The infusion schedule allows for regular monitoring and adjustment of therapy based on patient response.
Possible Side Effects of Remicade
While Remicade is generally effective, some patients may experience side effects, including infusion-related reactions such as fever, chills, and rash. Other potential side effects include infections, headache, and abdominal pain. Serious side effects can include an increased risk of infections, including tuberculosis, and rare but severe conditions like lupus-like syndrome or liver problems. It is crucial to monitor for any adverse effects and report them to your healthcare provider.
How infusion works at Prime
Remicade is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Remicade, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Remicade Work?
Remicade works by binding to TNF-alpha, a key protein involved in the inflammatory response. By inhibiting TNF-alpha, Remicade helps to reduce the inflammatory activity that contributes to symptoms and disease progression in conditions such as rheumatoid arthritis and inflammatory bowel disease. Remicade is administered through intravenous infusion, with the initial dose followed by additional doses at specified intervals based on the condition being treated.
Who is Remicade For?
Remicade is suitable for adults and children (6 years and older) with moderate to severe rheumatoid arthritis, Crohn’s disease, ulcerative colitis, or psoriatic arthritis who have not responded adequately to other treatments. It is also used for patients with ankylosing spondylitis and hidradenitis suppurativa. Remicade is recommended for individuals who require targeted therapy to manage inflammation and improve their quality of life.